The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.

Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek as Chief Financial Officer. Planishek brings deep experience scaling high-growth technology companies and will ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

At Korea Institute of Science and Technology (KIST), where research areas include materials, robotics and artificial intelligence, the team within its CJLab function were involved in Cas9 research.

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

If a pig embryo infused with human cells truly became something close enough to count as a member of the human species, then ...